PubRank

G K Hansson

Author PubWeight™ 137.00‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986 5.23
2 T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci U S A 1995 3.54
3 Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999 3.21
4 Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 2000 3.17
5 Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest 1991 2.76
6 Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J Clin Invest 1998 2.27
7 Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest 1985 2.16
8 T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler Thromb 1992 2.09
9 Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. Am J Pathol 1996 1.88
10 Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J Clin Invest 1992 1.83
11 Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. J Clin Invest 1998 1.80
12 Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain. Clin Exp Immunol 1986 1.70
13 In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation 2001 1.69
14 Nuclear factor kappa-B and the heart. J Am Coll Cardiol 2001 1.68
15 Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice. Circulation 2001 1.63
16 Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res 1992 1.56
17 Correlations between clinical variables and gene-expression profiles in carotid plaque instability. Eur J Vasc Endovasc Surg 2011 1.50
18 Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: possible implications for development of vascular proliferative lesions. Lancet 1988 1.46
19 Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler Thromb Vasc Biol 1996 1.41
20 Induction of tenascin in rat arterial injury. Relationship to altered smooth muscle cell phenotype. Am J Pathol 1991 1.39
21 LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler Thromb Vasc Biol 2001 1.39
22 Reduced frequency of memory CD8+ T lymphocytes in cerebrospinal fluid and blood of patients with multiple sclerosis. Autoimmunity 1995 1.39
23 Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury. Proc Natl Acad Sci U S A 1988 1.38
24 Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice. Atherosclerosis 1999 1.38
25 Polyclonal origin of T lymphocytes in human atherosclerotic plaques. Lab Invest 1991 1.35
26 Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2000 1.30
27 Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice. Proc Natl Acad Sci U S A 1999 1.28
28 Prelesional complement activation in experimental atherosclerosis. Terminal C5b-9 complement deposition coincides with cholesterol accumulation in the aortic intima of hypercholesterolemic rabbits. Lab Invest 1989 1.21
29 Activation of inducible nitric oxide synthase/nitric oxide by curli fibers leads to a fall in blood pressure during systemic Escherichia coli infection in mice. J Infect Dis 2001 1.19
30 Severe hypercholesterolaemia leads to strong Th2 responses to an exogenous antigen. Scand J Immunol 2004 1.19
31 Smooth muscle cells express Ia antigens during arterial response to injury. Lab Invest 1988 1.18
32 Interferon-gamma inhibits lipoprotein lipase in human monocyte-derived macrophages. Biochim Biophys Acta 1990 1.18
33 Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice. Scand J Immunol 1999 1.17
34 Endothelial dysfunction in response to psychosocial stress in monkeys. Circ Res 1991 1.14
35 Fc-mediated binding of IgG to vimentin-type intermediate filaments in vascular endothelial cells. Proc Natl Acad Sci U S A 1984 1.14
36 Complement receptors and regulatory proteins in human atherosclerotic lesions. Arteriosclerosis 1990 1.13
37 Immunohistochemical localization of lipoprotein lipase in human adipose tissue. Atherosclerosis 1984 1.12
38 Autoimmunity in atherosclerosis: a protective response losing control? J Intern Med 2008 1.12
39 Cellular immunity, low-density lipoprotein and atherosclerosis: break of tolerance in the artery wall. Thromb Haemost 2011 1.10
40 Evidence for antigen-driven T-cell response in unstable angina. Circulation 2000 1.09
41 Immunopathological features of rat Staphylococcus aureus arthritis. Infect Immun 1994 1.08
42 Differential expression of scavenger receptor isoforms during monocyte-macrophage differentiation and foam cell formation. Arterioscler Thromb 1994 1.07
43 Accumulation of IgG and complement factor C3 in human arterial endothelium and atherosclerotic lesions. Acta Pathol Microbiol Immunol Scand A 1984 1.07
44 Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. Circ Res 1998 1.06
45 Immune mechanisms in atherosclerosis. Coron Artery Dis 1994 1.06
46 Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery. Circ Res 1996 1.04
47 Human arterial smooth muscle cells in culture: inverse relationship between proliferation and expression of contractile proteins. In Vitro Cell Dev Biol 1989 1.04
48 Ultrastructural studies on the localization of IgG in the aortic endothelium and subendothelial intima of atherosclerotic and nonatherosclerotic rabbits. Exp Mol Pathol 1980 1.02
49 Nuclear factor-kappa B regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells. Circ Res 1999 1.01
50 The macrophage scavenger receptor type A directs modified proteins to antigen presentation. Eur J Immunol 1999 1.01
51 Expression of interleukin-15 in mouse and human atherosclerotic lesions. Am J Pathol 2001 1.00
52 Evidence for cell death in the vascular endothelium in vivo and in vitro. Am J Pathol 1983 1.00
53 Aortic endothelial cell death and replication in normal and lipopolysaccharide-treated rats. Am J Pathol 1985 1.00
54 Human arterial smooth muscle cells in culture. Effects of platelet-derived growth factor and heparin on growth in vitro. Exp Cell Res 1988 0.99
55 Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls. Ann Neurol 1993 0.98
56 Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions. J Clin Invest 1989 0.96
57 Expression of the macrophage scavenger receptor in atheroma. Relationship to immune activation and the T-cell cytokine interferon-gamma. Arterioscler Thromb Vasc Biol 1995 0.96
58 Fc-dependent binding of monocytes to areas with endothelial injury in the rabbit aorta. Exp Mol Pathol 1981 0.96
59 Augmented expression of inducible NO synthase in vascular smooth muscle cells during aging is associated with enhanced NF-kappaB activation. Arterioscler Thromb Vasc Biol 1999 0.96
60 MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor and lymphotoxin. Immunology 1990 0.95
61 The antiviral cytomegalovirus inducible gene 5/viperin is expressed in atherosclerosis and regulated by proinflammatory agents. Arterioscler Thromb Vasc Biol 2005 0.95
62 Retinoic acid regulates arterial smooth muscle cell proliferation and phenotypic features in vivo and in vitro through an RARalpha-dependent signaling pathway. Arterioscler Thromb Vasc Biol 1999 0.95
63 Expression of cyclo-oxygenase-2 in human atherosclerotic carotid arteries. Eur J Vasc Endovasc Surg 2000 0.95
64 Lipoprotein lipase in atherosclerosis: its presence in smooth muscle cells and absence from macrophages. J Lipid Res 1987 0.94
65 Isolation and characterization of endothelial cells from the epididymal fat pad of the rat. J Lipid Res 1983 0.93
66 Cytokine-induced expression of nitric oxide synthase results in nitrosylation of heme and nonheme iron proteins in vascular smooth muscle cells. Exp Cell Res 1994 0.92
67 Genetic variants of TNFSF4 and risk for carotid artery disease and stroke. J Mol Med (Berl) 2008 0.91
68 Unstable angina activates myocardial heat shock protein 72, endothelial nitric oxide synthase, and transcription factors NFkappaB and AP-1. Cardiovasc Res 2000 0.91
69 Scavenger receptors mediate adhesion of activated B lymphocytes. Exp Cell Res 1998 0.90
70 Immunological mechanisms in atherosclerosis. J Intern Med 1995 0.90
71 CD4+ and CD8+ T cell expansions using selected TCR V and J gene segments at the onset of giant cell arteritis. Arthritis Rheum 1994 0.90
72 Inducible and endothelial nitric oxide synthase expression during development of transplant arteriosclerosis in rat aortic grafts. Am J Pathol 1996 0.89
73 Plasma protein accumulation in injured endothelial cells. Immunofluorescent localization of IgG and fibrinogen in the rabbit aortic endothelium. Exp Mol Pathol 1979 0.89
74 Cyclosporine A inhibits induction of DNA synthesis by PDGF and other peptide mitogens in cultured rat aortic smooth muscle cells and dermal fibroblasts. Growth Factors 1991 0.89
75 Induction of nitric oxide synthase in a model of allergic occupational asthma. Allergy 1995 0.89
76 cDNA cloning and expression of inducible nitric oxide synthase from rat vascular smooth muscle cells. Biochim Biophys Acta 1994 0.89
77 Induction of CD36 by all-trans retinoic acid: retinoic acid receptor signaling in the pathogenesis of atherosclerosis. FASEB J 2001 0.89
78 IgG binding to cytoskeletal intermediate filaments activates the complement cascade. Exp Cell Res 1987 0.88
79 The contribution of inducible nitric oxide and cytomegalovirus to the stability of complex carotid plaque. J Vasc Surg 1999 0.88
80 Differential regulation of macrophage scavenger receptor isoforms: mRNA quantification using the polymerase chain reaction. J Lipid Res 1995 0.87
81 Immunologic control of vascular cell growth in arterial response to injury and atherosclerosis. Transplant Proc 1989 0.87
82 Endothelial proliferation and atherogenesis in rabbits with moderate hypercholesterolemia. Artery 1980 0.86
83 Apoptotic death of human leukemic cells induced by vascular cells expressing nitric oxide synthase in response to gamma-interferon and tumor necrosis factor-alpha. Cancer Res 1996 0.86
84 Enhanced phenylephrine-induced rhythmic activity in the atherosclerotic mouse aorta via an increase in opening of KCa channels: relation to Kv channels and nitric oxide. Br J Pharmacol 1999 0.86
85 Chemokines as potential therapeutic targets in atherosclerosis. Curr Drug Targets 2006 0.86
86 Antibody titers against oxidized LDL are not elevated in patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 1998 0.85
87 Severity of coronary artery stenosis is associated with a polymorphism in the CXCL16/SR-PSOX gene. J Intern Med 2005 0.85
88 Pyrrolidine dithiocarbamate-induced apoptosis depends on cell type, density, and the presence of Cu(2+) and Zn(2+). Am J Physiol Cell Physiol 2000 0.85
89 Expression of decay-accelerating factor on synovial lining cells in inflammatory and degenerative arthritides. Rheumatol Int 1992 0.83
90 HLA-DR expression in the vascular lesion and circulating T lymphocytes of patients with giant cell arteritis. Clin Exp Immunol 1988 0.83
91 Hyaluronic acid and chondroitin sulphate A rapidly promote differentiation of immature DC with upregulation of costimulatory and antigen-presenting molecules, and enhancement of NF-kappaB and protein kinase activity. Scand J Immunol 2002 0.81
92 Immune mechanisms in atherogenesis. Ann Med 1994 0.81
93 Adhesion of activated T lymphocytes to vascular smooth muscle cells and dermal fibroblasts is mediated by beta 1- and beta 2-integrins. Scand J Immunol 1992 0.80
94 Induction of neonatal tolerance to oxidized lipoprotein reduces atherosclerosis in ApoE knockout mice. Mol Med 2000 0.80
95 Retinoic acid inhibits nitric oxide synthase-2 expression through the retinoic acid receptor-alpha. Biochem Biophys Res Commun 2000 0.80
96 Infiltration of immunocompetent cells in the middle ear during acute otitis media: a temporal study. Am J Otol 1999 0.80
97 Electrocardiographic characterization of stress-induced myocardial infarction in atherosclerotic mice. Acta Physiol Scand 2005 0.80
98 An uneven expression of T cell receptor V genes in the arterial wall and peripheral blood in giant cell arteritis. Inflammation 2008 0.80
99 Abrogation of mitochondrial transcription in smooth muscle cells impairs smooth muscle contractility and vascular tone. J Physiol Pharmacol 2008 0.79
100 Immunohistochemical localization of plasminogen activators in human saphenous veins. Thromb Res 1986 0.79
101 Intermediate filaments in cultured human pleomorphic adenomas. An immunohistochemical study. Acta Pathol Microbiol Immunol Scand A 1985 0.79
102 Immunomodulation of atherosclerosis: myth and reality. J Intern Med 2000 0.79
103 Hydrogen peroxide induces mRNA for tumour necrosis factor alpha in human endothelial cells. Free Radic Res 1999 0.79
104 High endothelial cells of postcapillary venules express the scavenger receptor in human peripheral lymph nodes. Scand J Immunol 1995 0.79
105 Endothelial dysfunction and injury in atherosclerosis. Acta Med Scand Suppl 1987 0.79
106 Immunoglobulin treatment reduces atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice via the complement system. Clin Exp Immunol 2005 0.78
107 Hypertension and atherosclerosis. Cause and effect, or two effects with one unknown cause? Circulation 1991 0.78
108 Nitric oxide metabolites in CSF of patients with MS are related to clinical disease course. Neurology 1999 0.78
109 An immunohistochemical study of inducible nitric oxide synthase in the rat middle ear, with reference to tympanosclerosis. Acta Otolaryngol 1999 0.77
110 Platelets provoke distinct dynamics of immune responses by differentially regulating CD4+ T-cell proliferation. J Thromb Haemost 2014 0.77
111 Gene expression of inflammatory mediators in different chambers of the human heart. Ann Thorac Surg 2000 0.77
112 M-component with reactivity against actin associated with thrombotic thrombocytopenic purpura. Am J Med 1991 0.76
113 A system for long-term perfusion of rabbit aorta in vitro. Arteriosclerosis 1983 0.76
114 Functionality of specific immunity in atherosclerosis. Am Heart J 1999 0.76
115 Atherosclerosis: cell biology and lipoproteins. Curr Opin Lipidol 1998 0.76
116 In vivo determination of modulated migration of radiolabeled leukocytes. Arch Surg 1987 0.76
117 Expression of tenascin in arterial tissue. Am J Pathol 1993 0.75
118 Ischaemic heart disease in primary immunodeficiency. Lancet 1998 0.75
119 T lymphocytes in giant cell arteritic lesions are polyclonal cells expressing alpha beta type antigen receptors and VLA-1 integrin receptors. Clin Exp Immunol 1993 0.75
120 Mycobacterium bovis BCG killed by extended freeze-drying induces an immunoregulatory profile and protects against atherosclerosis. J Intern Med 2013 0.75
121 The collagen cross-linking enzyme lysyl oxidase is associated with the healing of human atherosclerotic lesions. J Intern Med 2014 0.75
122 Cellular and immunologic features of carotid artery disease in man and experimental animal models. Eur J Vasc Surg 1990 0.75
123 [Immunopathological mechanisms in atherosclerosis]. Lakartidningen 1976 0.75
124 Nitric oxide generation by nitric oxide synthase isoforms in transplanted vessels. Transplant Proc 1997 0.75
125 [Restenosis after coronary angioplasty. Studies on vascular walls give new hope for prevention]. Lakartidningen 1993 0.75
126 Endothelial structure in rabbits with moderate hypercholesterolaemia. A scanning electron microscopic study. Acta Pathol Microbiol Scand A 1977 0.75
127 Apolipoprotein B100 danger-associated signal 1 (ApoBDS-1) triggers platelet activation and boosts platelet-leukocyte proinflammatory responses. Thromb Haemost 2014 0.75
128 [Cerebrospinal fluid cytology--a valuable diagnostic method in various neurologic problems]. Lakartidningen 1990 0.75
129 Protein kinase C activation inhibits cytokine-induced nitric oxide synthesis in vascular smooth muscle cells. Biochim Biophys Acta 1994 0.75
130 [The Nobel Prize 1998 in physiology or medicine. Nitrogen oxide as a signal molecule in the cardiovascular system]. Ugeskr Laeger 1998 0.75
131 Solid-phase preparation of vimentin-type intermediate filaments for immunoassays. J Immunol Methods 1985 0.75
132 Re: The binding of immunoglobulins to cytoskeletal intermediate filaments. J Immunol Methods 1985 0.75
133 The uptake of 5-hydroxytryptamine in endothelial cells cultured from the pulmonary artery in rats. A cytochemical study. Acta Physiol Scand 1984 0.75